APA (7th ed.) Citation

Munseri, P. J., Kroidl, A., Nilsson, C., Joachim, A., Geldmacher, C., Mann, P., . . . Bakari, M. Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: A phase IIa randomized clinical trial. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Munseri, Patricia J., et al. Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen Followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Munseri, Patricia J., et al. Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen Followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial. Public Library of Science (PLoS).